3Collinson PO,Gaze DC. Biomarkers of cardiovascular damage and dysfunction an overview[J].Heart Lung and Circulation,2007,(Suppl 3):S71-S82.
4Gaze DC. Ischemia modified albumin:a novel biomarker for the detection of cardiac ischemia[J].Drug Metabolism and Pharmacokinetics,2009.333-341.
二级参考文献7
1Wu AHB, Apple FS, Gibler WB. et al. National Academy of Clinical Biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases[J]. Clin Chem, 1999,45 : 1104-1121.
2Panteghini M, Apple FS, Christenson RH, et al. Proposal from IFCC committee on standardization of markers of cardiac damage (C-SMCD) : Recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes[J]. Scan J Clin Lab Invest, 1999,59 : 103-112.
3The Joint European Society of Cardiology/American college of cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American college of cardiology Committee for the redefinition of myocardial infarction[ S].J Am Coll Cardial, 2000,36:959-969.
4Hamm CW. Cardiac-specific troponins in acute coronary syndromes[M]. In: Heart disease, ed. E Braunwald.WB Saunders coy, Philadelphia, 1997.
5Dean KJ. Biochemistry and molecular biology of troponin Ⅰ and T[M]. In: Cardiac markers, ed. AHB Wu. Humana Press Inc. New Jersey, 1998. 193-204.
6Montague C, Kirehfr T. Myoglobin in the early evaluation of acute chest pain[J]. Am J Clin Pathol, 1995,104:472-476.
7Christenson RH, Vaidya H, Landt Y, et al. Standardization of CK-MB mass assay: the use of recombinant CK-MB as a reference material[J]. Clin Chem, 1999,45 : 1414-1423.
